ORTIN GLOBAL LIMITED (ORTINGLOBE) financials

ORTIN GLOBAL LIMITED (ORTINGLOBE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Market Cap: ₹11.7Cr.
Current Price: ₹14.3
ROE: -48.4%
ROCE: -33.9%
Book Value: ₹1.52
Dividend Yield: 0.00%
52W High / Low: ₹21.3/10.7

In Jun 2026, ORTIN GLOBAL LIMITED (ORTINGLOBE) reported sales ₹0.01 Cr and net profit ₹-0.34 Cr.

Annual TTM: sales ₹0.33 Cr, net profit ₹-0.90 Cr.

Shareholding: Promoters 1.24% (Sep 2026), FIIs 0.67% (Sep 2026), Public 98.09% (Sep 2026), No. of Shareholders 11,151% (Sep 2026).

ORTINGLOBE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.05	0.03	0.09	0.08	0.01	0.01	0.30	0.01
Expenses	0.50	0.16	0.25	0.24	0.51	0.06	0.31	0.34
Operating Profit	-0.45	-0.13	-0.16	-0.16	-0.50	-0.05	-0.01	-0.33
OPM %	-900.00%	-433.33%	-177.78%	-200.00%	-5,000.00%	-500.00%	-3.33%	-3,300.00%
Other Income	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.02	-0.01	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.47	-0.10	-0.16	-0.16	-0.50	-0.05	-0.01	-0.33
Tax %	0.00%	10.00%	0.00%	6.25%	0.00%	0.00%	0.00%	0.00%
Net Profit	-0.47	-0.11	-0.16	-0.18	-0.50	-0.05	-0.01	-0.34
EPS in Rs	-0.58	-0.14	-0.20	-0.22	-0.61	-0.06	-0.01	-0.42
Raw PDF	—	—	—	—	—	—	—	—

ORTINGLOBE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	197.36	8.16	8.23	6.00	2.01	0.34	0.10	0.33
Expenses	191.66	6.92	7.85	5.47	6.40	1.23	1.13	1.22
Operating Profit	5.70	1.24	0.38	0.53	-4.39	-0.89	-1.03	-0.89
OPM %	2.89%	15.20%	4.62%	8.83%	-218.41%	-261.76%	-1,030.00%	-269.70%
Other Income	0.18	0.05	0.19	0.01	-1.98	0.06	0.31	0.00
Interest	3.21	0.87	0.81	0.40	0.48	0.00	0.00	0.00
Depreciation	1.96	0.29	0.29	0.25	0.23	0.01	0.00	0.00
Profit before tax	0.71	0.13	-0.53	-0.11	-7.08	-0.84	-0.72	-0.89
Tax %	181.69%	-623.08%	-24.53%	-18.18%	13.56%	1.19%	2.78%	—
Net Profit	-0.56	0.95	-0.40	-0.09	-8.04	-0.85	-0.74	-0.90
EPS in Rs	-0.33	1.17	-0.49	-0.11	-9.89	-1.05	-0.91	-1.10
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

ORTINGLOBE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16.94	16.94	8.13	8.13	8.13	8.13	8.13	8.13
Reserves	8.15	6.88	3.22	2.83	2.73	-5.31	-6.15	-6.89
Borrowings	19.47	19.57	6.94	6.14	6.45	1.80	0.25	1.01
Other Liabilities	60.53	73.13	2.97	3.61	3.89	2.05	1.55	2.40
Total Liabilities	105.09	116.52	21.26	20.71	21.20	6.67	3.78	4.65
Fixed Assets	21.29	22.45	14.38	14.21	13.96	0.01	0.00	0.01
CWIP	0.53	0.43	0.43	0.43	0.43	0.00	0.00	0.00
Investments	0.08	0.07	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	83.19	93.57	6.45	6.07	6.81	6.66	3.78	4.64
Total Assets	105.09	116.52	21.26	20.71	21.20	6.67	3.78	4.65

ORTINGLOBE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	6.52	3.30	18.03	2.15	-0.25	-4.79	-0.41	-0.56
Cash from Investing Activity	-3.27	-3.09	0.07	-0.13	0.01	12.00	0.00	0.04
Cash from Financing Activity	-2.89	-1.33	-9.86	-0.48	0.90	-3.49	0.33	0.75
Net Cash Flow	0.37	-1.12	8.25	1.55	0.66	3.72	-0.09	0.23
Free Cash Flow	3.38	0.28	18.03	2.02	-0.24	7.21	-0.41	-0.52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	104%	72%	1,454%	566%	-47%	80%	46%	54%

ORTINGLOBE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	1.23%	1.23%	1.23%	1.23%	1.23%	1.23%	1.23%	1.24%
FIIs	6.25%	6.53%	6.53%	1.68%	1.68%	1.68%	1.80%	0.67%
Public	92.52%	92.24%	92.24%	97.08%	97.09%	97.10%	96.96%	98.09%
No. of Shareholders	12,094	12,144	12,034	12,060	11,834	11,452	11,383	11,151

ORTINGLOBE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82.43	68.71	174.90	143.69	208.05	321.42	279.12	730.00
Inventory Days	100.07	117.80	169.10	136.29	279.94	4.92	34.76	0.00
Days Payable	145.12	155.80	123.82	61.88	166.89	7.87	69.52	—
Cash Conversion Cycle	37.38	30.70	220.17	218.10	321.10	318.47	244.36	730.00
Working Capital Days	16.82	11.24	-87.22	-109.10	-43.19	357.74	1,524.41	2,993.00
ROCE %	11.77%	8.94%	3.24%	1.58%	1.80%	-40.58%	-25.11%	-33.93%

ORTINGLOBEUpdated 17 Oct 2026, 20:44

Ortin Global Limited

ORTINGLOBEUpdated 17 Oct 2026, 20:44

Market Cap

₹11.7Cr.

Current Price

₹14.3

High / Low

₹21.3/10.7

ROE-48.4%

ROCE-33.9%

Book Value₹1.52

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1.57	0.11	1.39	0	0.06	0.01	0	0.02	0.02
Sep 2023	0.27	0.15	1.17	0	0.06	-1.11	1.8	-1.12	-1.38
Dec 2023	0.14	0.14	2.74	0	0.06	-2.8	-0.71	-2.79	-3.43
Mar 2024	0.3	0.08	3.35	0	0.05	-3.18	30.19	-4.14	-5.09
Jun 2024	0.21	0	0.31	0	0	-0.1	0	-0.1	-0.12
Sep 2024	0.05	0.02	0.5	0	0	-0.47	0	-0.47	-0.58
Dec 2024	0.03	-0.01	0.16	0.02	0	-0.1	10	-0.11	-0.14
Mar 2025	0.09	0	0.25	0	0	-0.16	0	-0.16	-0.2
Jun 2025	0.08	0	0.24	0	0	-0.16	6.25	-0.18	-0.22
Sep 2025	0.01	0	0.51	0	0	-0.5	0	-0.5	-0.61
Dec 2025	0.01	0	0.06	0	0	-0.05	0	-0.05	-0.06
Mar 2026	0.3	0	0.31	0	0	-0.01	0	-0.01	-0.01
Jun 2026	0.01	0	0.34	0	0	-0.33	0	-0.34	-0.42

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	60.29	3.52	53.8	0	1.64	1.33	32.33	0.9	0.53
Mar 2016	62.72	3.42	56.83	0.57	1.65	1.39	41.01	0.83	0.49
Mar 2017	61.57	2.94	56.12	0.32	1.7	1.13	55.75	0.5	0.3
Mar 2018	79.63	3.49	74.22	0.45	1.69	0.68	0	0.68	0.4
Mar 2019	167.51	3.22	160.83	0.13	1.75	1.84	30.43	1.28	0.76
Mar 2020	197.36	3.21	191.66	0.18	1.96	0.71	181.69	-0.56	-0.33
Mar 2021	8.16	0.87	6.92	0.05	0.29	0.13	-623.08	0.95	1.17
Mar 2022	8.23	0.81	7.85	0.19	0.29	-0.53	-24.53	-0.4	-0.49
Mar 2023	6	0.4	5.47	0.01	0.25	-0.11	-18.18	-0.09	-0.11
Mar 2024	2.01	0.48	6.4	-1.98	0.23	-7.08	13.56	-8.04	-9.89
Mar 2025	0.34	0	1.23	0.06	0.01	-0.84	1.19	-0.85	-1.05
Mar 2026	0.1	0	1.13	0.31	0	-0.72	2.78	-0.74	-0.91
TTM	0.33	0	1.22	0	0	-0.89	—	-0.9	-1.1

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	1.24%
FIIs	0.67%
Public	98.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	7.36%	0%	—	92.64%
Mar 2024	1.23%	0%	—	98.76%
Jun 2024	1.23%	6.25%	—	92.53%
Sep 2024	1.23%	6.25%	—	92.52%
Dec 2024	1.23%	6.25%	—	92.52%
Mar 2025	1.23%	6.53%	—	92.24%
Jun 2025	1.23%	6.53%	—	92.24%
Sep 2025	1.23%	1.68%	—	97.08%
Dec 2025	1.23%	1.68%	—	97.09%
Mar 2026	1.23%	1.68%	—	97.1%
Jun 2026	1.23%	1.8%	—	96.96%
Sep 2026	1.24%	0.67%	—	98.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	16.94	5.5	20.96	23.87	67.27	21.83	0	0.03	45.41	67.27
Mar 2016	16.94	6.33	20.85	21.22	65.34	21.63	0	0.03	43.68	65.34
Mar 2017	16.94	6.46	17.34	20.79	61.53	20.69	0.35	0.07	40.42	61.53
Mar 2018	16.94	7.14	17.34	32.24	73.66	20.03	0.4	0.08	53.15	73.66
Mar 2019	16.94	8.15	19.47	60.53	105.09	21.29	0.53	0.08	83.19	105.09
Mar 2020	16.94	6.88	19.57	73.13	116.52	22.45	0.43	0.07	93.57	116.52
Mar 2021	8.13	3.22	6.94	2.97	21.26	14.38	0.43	0	6.45	21.26
Mar 2022	8.13	2.83	6.14	3.61	20.71	14.21	0.43	0	6.07	20.71
Mar 2023	8.13	2.73	6.45	3.89	21.2	13.96	0.43	0	6.81	21.2
Mar 2024	8.13	-5.31	1.8	2.05	6.67	0.01	0	0	6.66	6.67
Mar 2025	8.13	-6.15	0.25	1.55	3.78	0	0	0	3.78	3.78
Mar 2026	8.13	-6.89	1.01	2.4	4.65	0.01	0	0	4.64	4.65

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-1.38	0.22	1.73	0.58
Mar 2016	0.52	-0.86	0.27	-0.07
Mar 2017	1.94	-1.26	-0.82	-0.14
Mar 2018	1.56	-0.9	0.07	0.73
Mar 2019	6.52	-3.27	-2.89	0.37
Mar 2020	3.3	-3.09	-1.33	-1.12
Mar 2021	18.03	0.07	-9.86	8.25
Mar 2022	2.15	-0.13	-0.48	1.55
Mar 2023	-0.25	0.01	0.9	0.66
Mar 2024	-4.79	12	-3.49	3.72
Mar 2025	-0.41	0	0.33	-0.09
Mar 2026	-0.56	0.04	0.75	0.23

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	103.77	53.13	90.35	100.15	82.43	68.71	174.90	143.69	208.05	321.42	279.12	730.00
Inventory Days	192.30	148.72	158.21	152.21	100.07	117.80	169.10	136.29	279.94	4.92	34.76	0.00
Days Payable	151.09	24.82	108.10	143.09	145.12	155.80	123.82	61.88	166.89	7.87	69.52	—
Cash Conversion Cycle	144.97	177.04	140.45	109.28	37.38	30.70	220.17	218.10	321.10	318.47	244.36	730.00
Working Capital Days	29.00	16.24	37.29	41.48	16.82	11.24	-87.22	-109.10	-43.19	357.74	1,524.41	2,993.00
ROCE %	12.07%	10.92%	9.57%	9.44%	11.77%	8.94%	3.24%	1.58%	1.80%	-40.58%	-25.11%	-33.93%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ORTIN GLOBAL LIMITED (ORTINGLOBE)?

The reported market capitalisation for ORTIN GLOBAL LIMITED (ORTINGLOBE) is ₹11.7Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ORTINGLOBE?

The current price shown for ORTIN GLOBAL LIMITED (ORTINGLOBE) on Fincrux is ₹14.3 with a 52-week high/low of ₹21.3/10.7.

What were ORTINGLOBE latest quarterly results?

For Jun 2026, ORTIN GLOBAL LIMITED (ORTINGLOBE) reported sales ₹0.01 Cr and net profit ₹-0.34 Cr (figures in ₹ crore unless noted).

What are ORTINGLOBE annual sales and net profit?

For TTM, ORTIN GLOBAL LIMITED (ORTINGLOBE) shows sales of ₹0.33 Cr and net profit of ₹-0.90 Cr on the Fincrux profit & loss statement.

Who owns ORTIN GLOBAL LIMITED (ORTINGLOBE)?

Latest shareholding for ORTIN GLOBAL LIMITED (ORTINGLOBE) on Fincrux: Promoters 1.24% (Sep 2026), FIIs 0.67% (Sep 2026), Public 98.09% (Sep 2026), No. of Shareholders 11,151% (Sep 2026).

Where can I find ORTIN GLOBAL LIMITED (ORTINGLOBE) financials?

ORTIN GLOBAL LIMITED (ORTINGLOBE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ORTINGLOBE balance sheet and cash flow?

Yes. The ORTIN GLOBAL LIMITED (ORTINGLOBE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 October 2026 at 20:44